153172-30-6 Usage
Complex organic compound
It is a complex organic compound that contains a variety of functional groups.
Functional groups
It has an amino group, an anhydro group, a benzyl group, a tertbutyldimethylsilyl group, and an isopropylidene group.
Deoxyribitol backbone
It has a deoxyribitol backbone.
Organic synthesis and chemical research
It is often used in organic synthesis and chemical research due to its unique structure and reactivity.
Potential applications
It may have potential applications in the pharmaceutical industry or in materials science due to its diverse chemical properties.
Chemical structure
The compound has a complex chemical structure with multiple functional groups and a deoxyribitol backbone.
Reactivity
The compound is known for its unique reactivity, which makes it useful in various chemical reactions.
Research and development
It is a compound of interest in research and development due to its potential applications in various fields.
Pharmaceutical industry
It may have potential applications in the pharmaceutical industry due to its diverse chemical properties.
Materials science
It may also have potential applications in materials science due to its unique structure and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 153172-30-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,1,7 and 2 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 153172-30:
(8*1)+(7*5)+(6*3)+(5*1)+(4*7)+(3*2)+(2*3)+(1*0)=106
106 % 10 = 6
So 153172-30-6 is a valid CAS Registry Number.
153172-30-6Relevant articles and documents
ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES
-
Page/Page column 96-97, (2014/06/11)
Disclosed are compounds comprising an azasugar attached to a heterocyclic base, including pharmaceutically acceptable salts thereof, suitable for use in inhibiting viral RNA polymerase activity or viral replication, and treating viral infections. The compounds are characterized, in part, by favorable pharmacokinetics for the active pharmaceutical ingredient, particularly in conjunction with enteral administration, including, in particular, oral administration. Also disclosed are pharmaceutical compositions comprising one or more compounds mentioned above, or pharmaceutically acceptable salts thereof, as well as methods for preparing same. Also provided are methods for inhibiting viral RNA polymerase activity, viral replication, and treating viral infections.
Inhibition of LuxS by S-ribosylhomocysteine analogues containing a [4-aza]ribose ring
Malladi, Venkata L.A.,Sobczak, Adam J.,Meyer, Tiffany M.,Pei, Dehua,Wnuk, Stanislaw F.
experimental part, p. 5507 - 5519 (2011/11/06)
LuxS (S-ribosylhomocysteinase) catalyzes the cleavage of the thioether linkage of S-ribosylhomocysteine (SRH) to produce homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD), the precursor to a small signaling molecule that mediates interspecies bacteria
